Dare Bioscience, Inc. 8-K

What Happened
Daré Bioscience, Inc. announced on January 6, 2026 that it made an updated corporate presentation available in the "Investors" section of its website (https://ir.darebioscience.com). The presentation is dated January 6, 2026 and was furnished as Exhibit 99.1 to the company's Form 8-K filed the same day under Regulation FD disclosure; the exhibit is incorporated by reference into the filing.

Key Details

• Date of disclosure: January 6, 2026.
• Location: Investor Relations page on Daré’s website (https://ir.darebioscience.com).
• Exhibit filed: Exhibit 99.1 — Daré Bioscience corporate presentation dated January 6, 2026.
• Filing type: Form 8-K, Item 7.01 (Regulation FD Disclosure); exhibit incorporated by reference.

Why It Matters
An updated investor presentation provides shareholders and potential investors with the company’s latest publicly disclosed overview of strategy, programs, and corporate information in a single document. By filing under Regulation FD and furnishing the presentation as an exhibit to a Form 8-K, Daré ensured the information was publicly available and broadly disclosed to the market at the same time. This filing does not report earnings, management changes, or other financial statements.